Lumos Pharma | NLNK - القيمة السوقية



القيمة السوقية تغيير تاريخ
Agenus USD 107M 16M 2025-12
Alterity Therapeutics Limited AUD 30M 26M 2026-04
Bristol-Myers Squibb USD 109.81B 18.01B 2025-12
Capricor Therapeutics USD 1.66B 1.33B 2025-12
Celldex Therapeutics USD 1.81B 87M 2025-12
Cipla INR 1.22T 6.47B 2025-12
Clal Biotechnology ILS 43.45M 8.92M 2026-03
Compugen USD 144.67M 7.17M 2025-12
CSL USD 55.89B 20.42B 2025-12
Eli Lilly USD 1.02T 293.84B 2025-12
Incyte USD 19.39B 2.83B 2025-12
Merck USD 261.26B 51.62B 2025-12
Nektar Therapeutics USD 14.34B 13.48B 2026-04
Pfizer USD 141.57B 6.48B 2025-12
Prothena USD 514M 11M 2025-12
Sarepta Therapeutics USD 2.26B 238M 2025-12